Announcement
Bhupendra Tank, David J. Margolis, Angelo Valerio Marzano(University of Milan), Christos C. Zouboulis(Freie Universität Berlin), Florence Dalgard(Oslo University Hospital), José A. Campillo, Christine Neumann, T. Gambichler, Stefanie Boms(Skin Cancer Foundation), Markus Meißner(Goethe University Frankfurt), Walter Volpi, Anne‐Chantal Knol, Amir Khammari, N. H. Brockmeyer, Rüdiger Eming(Philipps University of Marburg), Evgenia Makrantonaki, Gil Yosipovitch(University of Miami), Paolo Fabbri, Michael Hertl(Universitätsklinikum Gießen und Marburg), Armand Bensussan(Université Mohammed VI Polytechnique), Rocío López-Álvarez, María R. López-Álvarez, Ullrich Krüger, Daniele Fanoni(University of Milan), Luis Marı́n, Donatella Schena(University of Verona), Luigia Venegoni, Clara De Simone(IRCCS San Camillo Hospital), Luca Borradori(University Dermatology), Meike Distler, Alfredo Minguela, Markus Zutt, Emilio Berti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Aurora Parodi(Ospedale Policlinico San Martino), Maria Grazia Bernengo(University of Turin), Aerlyn G. Dawn, A. Brocard, Jorge Martínez‐Escribano(Hospital Universitario Virgen de la Arrixaca), Ana M. García-Alonso(Hospital Universitario Virgen de la Arrixaca), M. Stücker, Manabu Ohyama(Kyorin University), R. Kaufmann, Arnold P. Oranje(Erasmus MC), R. Caputo, Youichi Nishimura, E. Haas, Brigitte Dréno(Nantes Université)
Cited by 0
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k